GENOTECH CORP. Logo

GENOTECH CORP.

A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.

066830 | KO

Overview

Corporate Details

ISIN(s):
KR7066830001
LEI:
Country:
South Korea
Address:
대전광역시 유성구 가정북로 26-69, 대전광역시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Genotech Corp. is a South Korea-based biotechnology company that engages in the production and sale of pharmaceutical and biological products. The company's core activities include providing products and services for gene synthesis, genome analysis, and biopharmaceuticals. It also manufactures basic pharmaceutical substances and biological agents, offering related technical and academic services to both domestic and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-19 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.6 KB
2025-06-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.3 KB
2025-03-31 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-26 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 89.5 KB
2025-03-24 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 19.9 KB
2025-03-14 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 320.9 KB
2025-03-11 00:00
Audit Report / Information
감사보고서제출
Korean 9.7 KB
2025-03-04 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 103.5 KB
2025-02-25 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.6 KB
2024-12-06 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-13 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2024-10-30 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2024-09-05 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 57.1 KB
2024-08-16 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 85.7 KB
2024-08-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.0 KB

Automate Your Workflow. Get a real-time feed of all GENOTECH CORP. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENOTECH CORP.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENOTECH CORP. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Apellis Pharmaceuticals, Inc. Logo
Developing novel C3 therapies for diseases in ophthalmology, nephrology, and hematology.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Biopharma developing non-narcotic bee venom therapies for osteoarthritis pain and inflammation.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Developing novel antibody biologics for immunological and inflammatory (I&I) diseases.
United States of America
APGE
Apollomics Inc. Logo
A clinical-stage biopharma developing targeted oncology therapies for hard-to-treat cancers.
United States of America
APLM
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany
APPH
Develops DNA tech for genetic medicine, molecular diagnostics, and supply chain security.
United States of America
APDN
Applied Therapeutics, Inc. Logo
Develops treatments for rare metabolic and central nervous system (CNS) disorders.
United States of America
APLT
Aprea Therapeutics, Inc. Logo
Developing precision cancer therapies targeting DNA Damage Response for solid tumors.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea
397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea
003060

Talk to a Data Expert

Have a question? We'll get back to you promptly.